Suchergebnisse - "Tran, Ben"

PubPharm (217)

1

A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia

enthalten in: Asia-Pacific journal of clinical oncology | 2024

von Marx, G. | Chowdhury, S. | Krieger, L. | +6

2

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Dorff, T. | Horvath, L. | Autio, K. | +25

3

Carboplatin in Metastatic Castrate Resistant Prostate Cancer : A Retrospective Study of Heavily Pretreated Patients (COMPACT)

enthalten in: Clinical genitourinary cancer | 2024

von Pemberton, L. | Allen, C. | Handel, E. | +6

4

CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

enthalten in: Cancer discovery | 2024

von Pal, S. | Tran, B. | Haanen, J. | +22

5

Self-perceptions of masculinities and testicular cancer : Qualitative explorations

enthalten in: Psycho-oncology | 2024

von Dax, V. | Ftanou, M. | Tran, B. | +5

6

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2024

von Hofman, M. | Tran, B. | Feldman, D. | +7

7

Objective response rate and progression-free survival as surrogates for overall survival treatment effect : A meta-analysis across diverse tumour groups and contemporary therapies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Shahnam, A. | Hitchen, N. | Nindra, U. | +8

8

Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-Pacific

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2024

von Kikuchi, E. | Ng, C. | Kitamura, H. | +12

9

Changing trends in phase 1 oncology clinical trials

enthalten in: Contemporary clinical trials communications | 2024

von Kelly, R. | Guo, C. | Desai, J. | +1

10

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations : cohort 2 of the randomized phase III THOR trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Siefker-Radtke, A. | Matsubara, N. | Park, S. | +113

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]